Top Markets
Coin of the day
Oscotec Inc. Oscotec Inc.

Oscotec Inc.

039200
Rankning i aktier #9790
Oscotec Inc. is a biopharmaceutical company specializing in the discovery and... Oscotec Inc. is a biopharmaceutical company specializing in the discovery and development of novel therapeutic drugs. Its primary focus lies in advancing a pipeline of investigational medicines, including a SYK inhibitor currently in Phase IIa clinical trials for the treatment of both rheumatoid arthritis and immune thrombocytopenia. Another key asset is an FLT3 inhibitor, undergoing Phase I clinical evaluation for acute myeloid leukemia. The company is also developing an EGFR double mutation inhibitor aimed at non-small cell lung cancer, and an Anti-Tau antibody in the preclinical stage for Alzheimer's disease. Beyond its pharmaceutical endeavors, Oscotec Inc. diversifies its offerings with a range of dental health products, such as bone graft materials like InduCera, BioCera-F, and SynCeraII, alongside membranes including LysoGide and CollaGuide. Additionally, it markets functional ingredients designed to address specific health concerns, such as OPB for osteoporosis, AIF for arthritis, SGA for enhancing bone growth, and PRF-K for periodontal conditions. Established in 1988, the company, originally known as Oscotec Co., Ltd, adopted its current name, Oscotec Inc., in June 1999. It is headquartered in Seongnam, South Korea.
Aktiekurs
$24.76
Senast synkroniserad: 2026-08-28
Marknadsvärde
$947.10M
Förändring (1 dag)
2.14%
Förändring (1 år)
-6.44%
Land
KR
Handel Oscotec Inc. (039200)

Kategori

Utdelningsavkastning för Oscotec Inc. (039200)
Utdelningsavkastningen (TTM) för Oscotec Inc. (aktiesymbol: 039200) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för Oscotec Inc. (039200) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter
Företag Utdelningsavkastning Land
0.57%
US
2.01%
US
2.74%
US
2.69%
CH
2.47%
US